Mexico City resident Alejandra Gaehd, who has long suffered from tonic-clonic seizures, has been able to return to a normal life following a minimally invasive procedure performed by UTHealth Houston neurosurgeon Nitin Tandon, MD.
Hackensack Meridian Jersey Shore University Medical Center recently welcomed Board Certified Neurosurgeon Shabbar F. Danish, M.D., FAANS, as Chair of Neurosurgery as part of the academic medical center’s Neuroscience Institute.
After experiencing a medical emergency, Don Cohn is giving back to the department that he credits with saving his life.
Department of Rehabilitation and Human Performance will lead Mount Sinai in national clinical trial
The hospital achieved this recognition by meeting rigorous standards for performing endovascular thrombectomy and demonstrating continuous compliance with its performance standards.
Study finds stroke patients are nearly twice as likely to be functionally independent if treated by a specialized team that travels to them to perform surgical clot removal
Cedars-Sinai researchers have identified a set of brain cells that, when affected by epilepsy, cause memory impairment in patients with a particular type of the disorder called temporal lobe epilepsy (TLE).
Wolters Kluwer, Health announced a multi-year agreement reestablishing its collaboration with the Congress of Neurological Surgeons (CNS), the leading organization dedicated to advancing neurosurgery through education and innovation. Beginning in January 2022, Wolters Kluwer will publish three medical specialty journals from CNS’s portfolio including its flagship publication Neurosurgery, one of the most highly cited neurosurgery journals in the world.
Announcement of the August issue Neurosurgical Focus
Of the more than 3,000 U.S. hospitals evaluated, Rush University Medical Center ranked No. 19 in the nation by U.S. News & World Report, with nine of specialties rated among the country’s very best.
A new method of gene therapy is helping children born with a rare genetic disorder called AADC deficiency that causes severe physical and developmental disabilities. The study was led by researchers at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine.
Announcement of July issue of Neurosurgical Focus: Video
Announcement of Neurosurgical Focus’s 25th anniversary as well as listing the articles in the July issue
Today, Penn Medicine launches the Penn Nerve Center, which unites experts across disciplines to offer expert diagnosis and cutting-edge treatment for a wide range of nerve conditions including traumatic nerve injuries, nerve entrapment, nerve compression, and nerve tumors. Combining experts in neurosurgery, orthopaedics, plastic surgery, physical medicine and rehab, neurology, and radiology, the Center is the first of its kind in the region.
Ellen Air, M.D., Ph.D., director of the Neurosurgery Residency Program at Henry Ford Health System and Chair-Elect of the American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Joint Section on Women in Neurosurgery, is co-author of a new Professionalism and Harassment Model Policy created to provide a code of ethical behavior that promotes professional growth and the free exchange of ideas at neurosurgical meetings, educational courses, conferences and other sponsored events.
When Kathy Shelly recalls the planning involved in scheduling her 20-week anatomy ultrasound so that her husband, Don Shelly, could also attend the appointment nearly 31 years ago, she thanks God that Don was able to be there. “I am just so grateful I didn’t have to be alone in that moment,” she said.
Announcement of articles in the March 2021 issue of Neurosurgical Focus.
The Parkinson’s Disease and Movement Disorder Center at Henry Ford Health System was the first in the United States to offer a new FDA-approved device to help treat the symptoms of Parkinson’s disease. Neurosurgeon Jason Schwalb, M.D. surgically implanted the Vercise Genus™ Deep Brain Stimulation (DBS) System, which stimulates a targeted region of the brain through implanted leads that are placed in the brain.
Research by scientists at the University of Miami Miller School of Medicine has shown that sodium fluorescein, a sodium salt and organic fluorescent dye that makes vestibular schwannoma tumors glow neon green, may help surgeons improve the safety and outcomes of an otherwise complicated brain surgery.
When doctors couldn’t pinpoint the location of Giorgia’s seizures, they doubled down, using innovative tools to target and treat her epilepsy.
Netflix, a leading streaming entertainment service featuring TV series, documentaries and feature films across a wide variety of genres and languages, will soon begin airing a new documentary series, “The Surgeon’s Cut,” which features an episode about Alfredo Quinones-Hinojosa, M.D., a Mayo Clinic neurosurgeon.
Introduces topic and lists content for the December issue of Neurosurgical Focus.
Story of a man who celebrated his five-year survival with GBM. He received 5-ALA prior to surgery, which helps the surgeon see more of the tumor for removal, and he was in a Phase 1 clinical trial.
Announcement of University Hospitals Cleveland Medical Center and UH Seidman Cancer Center obtaining the Medtronic Stealth Autoguide cranial robotic guidance platform for neurosurgery.
Article presents the topic and articles of the November issue of Neurosurgical Focus.
To determine the frequency of medical malpractice suits among neurosurgeons and neurosurgeons’ reactions when faced with the prospect of such lawsuits, three researchers from The Netherlands surveyed members of the Congress of Neurological Surgeons. The results of the survey can be found in this article
At 3 a.m. in early September, when most people were still in their beds, more than 400 viewers in China were logged in to a special broadcast, translated in Chinese, focused on neuro-tech and global neurosurgery issues. They were among the thousands of neurosurgeons, residents, medical students and other professionals who tuned in each day to a massive, three-day Global Neurosurgery symposium in September, “Global Neurosurgery: Ask Not for Whom the Bell Tolls.”
Dopamine and serotonin are at work at sub-second speeds to shape how people perceive the world and take action based on their perception. The discovery shows researchers can simultaneously measure the activity of both dopamine and serotonin in disorders ranging from depression to Parkinson’s disease.
Hackensack Meridian Jersey Shore University Medical Center recently opened the Center for Advanced Skull Base Surgery, providing treatment for adults and children with tumors and other abnormalities of the cranial base.
Announcement of contents of the October issue of Neurosurgical Focus: Video
Announcement of Nicholas C. Bambakidis, MD, Vice President and Director of the Neurological Institute at University Hospitals in Cleveland, recent election as President-Elect of the Congress of Neurological Surgeons.
MONTCLAIR, New Jersey (September 8, 2020) – Mountainside Medical Center has announced that Robert. F. Heary will take on the new role as Medical Director of the Spine Program. In this new role, Dr. Heary will oversee the Montclair Spine Center at Mountainside Medical Center to ensure the organization and delivery of excellent, timely, evidence-based care.
Penn Medicine researchers found that when an “Enhanced Recovery After Surgery” protocol was employed—which optimizes patients’ surgical care before, during, and after surgery—the majority of patients did not need opioids for pain management at one, three, and six months after elective spinal and peripheral nerve surgery.
In the midst of the extraordinary health challenge presented by the COVID-19 pandemic, Baylor Scott & White Health remains committed to quality, safe care and helping Texas communities navigate the uncertainty of the SARS-CoV-2 virus. Today, this commitment to safety and quality is recognized as U.S. News & World Report releases its 2020-2021 Best Hospitals list.
The Mount Sinai Hospital, the flagship hospital of Mount Sinai Health System, was listed among the nation’s top hospitals for care excellence in U.S. News and World Report, marking the fifth straight year the hospital has been listed among the top 20 in the country while landing on the distinctive “Honor Roll” list.
Announcement of contents of the July 2020 issue of Neurosurgical Focus: Video.
Announcement of the contents of the 2020 July issue of Neurosurgical Focus.
An innovative use of focused ultrasound is showing promise against glioblastoma, the deadliest brain tumor, and could prove useful against other difficult-to-treat cancers.
For patients with brain arteriovenous malformations, not having surgery or getting radiation therapy can result in an almost 70-per-cent lower risk of having a stroke or dying, reseachers find.
Presidential appointment, Executive committee members, First virtual Board of Directors, Business meetings for Association.
Listing of new editorials on the impact of the COVID-19 pandemic on the practice of neurosurgery
Beginning on April 10th, the Journal of Neurosurgery Publishing Group (JNSPG), the scholarly journal division of the American Association of Neurological Surgeons, presents a series of editorials on the impact of the COVID-19 pandemic on the practice of neurosurgery.
Daniel Yoshor, MD, has been named chair of the department of Neurosurgery in the Perelman School of Medicine at the University of Pennsylvania and vice president of Clinical Integration and Innovation for the University of Pennsylvania Health System.
Announces the theme and contents of the March 2020 issue of Neurosurgical Focus, an online peer-reviewed journal.
University Hospitals Seidman Cancer Center treated its first patient in a new clinical trial to validate the groundbreaking effects of the poliovirus on glioblastoma (GBM), a deadly Grade IV cancer of the brain.
UH is the only Midwest site participating in this clinical trial, which was initiated at Duke Cancer Institute in Durham, NC. The original study, which ran from 2012-2017, was published in New England Journal of Medicine in July 2018 as well as highlighted on “60 Minutes” in 2015 and again in 2018. The study found that survival rates were significantly higher in glioblastoma patients who received an intratumoral infusion of a modified viral chimera combining the polio and rhinoviruses (PVSRIPO immunotherapy) compared to patients receiving standard treatment at the same institution.
New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer’s, as a biomarker for glioma development.
Dolores Hambardzumyan, PhD, MBA, has been appointed Senior Faculty in the Department of Neurosurgery and a member of The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.
The Department of Neurosurgery at the Icahn School of Medicine at Mount Sinai has received more than $10 million in federal funding for several projects focusing on brain tumor research.
The Ray Charles Foundation has made an investment in the future, donatng $1 million to fund a new neurosurgery scholarship program at Cedars-Sinai. Under the direction of Dr. Keith Black, scholarship recipients will receive personalized, mentored research training from neurosciences faculty members while conducting their own research projects.
UC San Diego launches new Center for Fluorescence-Guided Surgery. The center builds upon Roger Tsien’s legacy, delivering a new caliber of surgical precision to treat patients with tumors and disease of all types, identifying unhealthy tissues with a fluorescent glow.